Category Archives for News

Cenegenics Physician, George C. Shapiro, MD, FACC, Is Honored as a 2016 Top Doctor in New York City, New York

NEW YORK, NY–(Marketwired – May 20, 2016) –  Cenegenics Elite Health physician George C. Shapiro, MD has been named a 2016 Top Doctor in New York City, New York. Dr. Shapiro is a highly respected Cardiologist and Age Management Medicine specialist at 40 Wall Street in NYC and 4 Westchester Park Drive in Westchester County NY, and is affiliated with New York Presbyterian Hospital. Top Doctor Awards are given to healthcare practitioners who have demonstrated clinical excellence while delivering the highest standards of patient care.

Dr. George C. Shapiro has been in practice for over 27 years. His career in medicine began in 1988 when he graduated from New York Medical College. An internship and residency then followed at Albert Einstein college of Medicine, after which, Dr. Shapiro completed a Cardiovascular Disease fellowship at Columbia University College of Physicians and Surgeons in 1994.

Dr. Shapiro has long been known as one of New York’s foremost Cardiologist, specializing in regenerative medicine and improving longevity including the Genomics of cardiovascular disease and congestive heart failure. He has also become known nationwide as an expert in Age Management Medicine, with a special focus in the prevention of heart disease and strokes. As such, he is an active member of 13 medical societies and organizations, and is a speaker for the Age Medicine Management Group.

Dr. Shapiro has often appeared on radio stations, as well as acting as a consultant for several television shows. When not working he continues to serve his community as a Deputy Chief Police Surgeon for the NY State Troopers and member of the Westchester County Department of Special Operations HAZ-MAT team where he is an Advanced HAZ-MAT Technician.

He is also recognized for his research and innovations, and has patented several medical devices. This voracious community spirit and desire to advance the cause of Age Management Medicine makes Dr. George C. Shapiro a very worthy winner of a 2016 Top Doctor Award.

About Top Doctor Awards

Top Doctor Awards specializes in recognizing and commemorating the achievements of today’s most influential and respected doctors in medicine. Our selection process considers education, research contributions, patient reviews, and other quality measures to identify top doctors

Raising the Bar for Preventive Medical Approach: Healthy Aging Global Leader Offers Life Length’s Telomere Test

LAS VEGAS, NV (PRWEB) FEBRUARY 08, 2012

Life Length®, the leading telomere testing and services company, announced an agreement with Cenegenics® Medical Institute to offer the test to its more than 20,000 patients—including 2,000 doctors and their families—through its nationwide network of 19 facilities and 100 physician affiliates.

Stephen J. Matlin, CEO, Life Length said, “We are delighted to partner with Cenegenics, the world’s largest age management practice and recognized leading authority in their field, helping patients age healthily through proactive, preventive medicine. Life Length’s test will help raise the bar further since telomeres are best predictors of biological age and excellent general health indicators. Through Cenegenics, the Life Length Telomere Analysis Technology (TAT) will become a key test of age management.”

Dr. Robert D. Willix, Jr., Cenegenics’ Chief Medical Officer, noted, “We are pleased to partner with Life Length to provide extremely accurate analyses of critically short telomeres, those primarily responsible for aging and age-related diseases. We will encourage all our patients to be tested regularly to assess one of the best biomarkers and determine their biological versus chronological age.The test will expand a patient’s health evaluation and take it to the next level.”

bout Life Length 
Life Length, a life sciences company founded in 2010 to commercially exploit TAT developed by Dr. Maria Blasco, Chief Scientific Advisor, Life Length and Director, Spanish National Cancer Research Centre, provides testing services to pharmaceutical and biotech industries for drug R&D and clinical trials, as well as to the general public through physicians and clinics interested in telomere indicators of biological age and overall health. Life Length is the first company offering such precise testing. The founding partners are the Botin Foundation, Dr. Blasco and Matlin Associates. 

About Cenegenics 
Cenegenics® Medical Institute has forged a paradigm shift in medicine, developing a proactive medical approach for optimized health hailed as “next generation medicine” and garnering worldwide media attention. Cenegenics has 19 centers with others opening in the near future: Las Vegas, Nevada (headquarters); Charleston, SC; Boca Raton, Florida; Dallas, Texas; Arlington, Texas; Atlanta, Georgia; Chicago, Illinois; Beverly Hills, California; Philadelphia, Pennsylvania; Washington, DC; New York City, NY; Tulsa, OK; Jacksonville, FL; Atlantic City, NJ; Houston, TX; Denver, CO; Scottsdale, AZ; Boston, MA. Cenegenics serves over 20,000 patients globally—2,000 are physicians and their families.

Medical Experts Disagree With FDA on Testosterone Risks

LAS VEGAS, NV–(Marketwired – May 09, 2016) – Cardiovascular disease is the number one cause of death in the US, taking more lives than all forms of cancer combined. Therefore, the physicians at Cenegenics Elite Health understand that testosterone replacement in deficient men not only improves quality of life, but can also be an integral part of an overall program to reduce the risk of heart attack and stroke.

While the public controversy about the potential dangers of testosterone replacement has subsided somewhat, we are still left with FDA warning labels suggesting that testosterone is likely to cause harm to patients with heart disease. This is in stark contrast to the opinion of the majority of medical experts who disagree with the FDA’s position, including the two major endocrinology societies.

There have been numerous articles refuting the studies that started the controversy. The most recent comes from The Journal of the American College of Cardiology titled “Testosterone and Cardiovascular Disease – State of the Art Review.” Among the items discussed in the review were:

  • The two studies that suggested adverse outcomes in men treated with testosterone had significant flaws that limit drawing any meaningful medical conclusions.
  • Numerous studies with good methodology, both before and after the above studies were published, indicate just the opposite — that testosterone replacement, in men with low levels, reduced the risk of heart attacks and strokes, and did not increase the risk of blood clots.

To date, the FDA has refused to lift the warnings on testosterone products, despite the fact that their recommendations are not supported by the vast majority of medical literature, or by experts in the field. This is especially disconcerting when it is well known that many over the counter medications such as ibuprofen and naproxen are known to double the risk of heart attacks and stroke. These common medications are used daily by a much larger segment of the population, dwarfing the number of patients on testosterone.

For an interview or to learn more about Cenegenics’ individualized approach to reduce the risk of heart attack and stroke utilizing advanced risk assessment tools, correction of metabolic deficiencies, individualized nutrition and exercise plans along with targeted nutritional supplementation, contact Kristy Berry at kberry@cenegenics.com.More from our newsroom

CNBC.com Investigates Testosterone Use on Wall Street, Goes to Cenegenics for Answers

LAS VEGAS, NV (PRWEB) JULY 13, 2012

CNBC.com staff writer Cindy Perman features Cenegenics’ healthy aging protocols and Cenegenics New York City’s CEO/Chief Medical Officer, Dr. George Shapiro, in her article “Wall Street’s Secret Weapon for Getting an Edge,” announced Cenegenics® Medical Institute. Perman keys in on factors of testosterone therapy and how physicians such as Shapiro and his medical colleagues at the Cenegenics Wall Street center are helping patients overcome presumed age-related symptoms—“sluggish feeling, muscle aches, belly fat, low stamina, low sex drive and lack of focus”—and get their game back.

Shapiro, like his New York patients, had all the telltale signs of living a hectic 21st century lifestyle. The Cenegenics program proved a real game changer for him, personally and professionally. His body fat dropped from 31% to 16%, his energy and focus returned and he became trained/certified in age management medicine to offer patients that same level of transformation.

“Our patients get remarkable results—truly a polar shift from where they were. It’s a pleasure to guide them into a totally new dimension of health they never dreamed of, using the synergy of the right exercise, low-glycemic nutrition, nutraceuticals and hormone therapy if clinically indicated,” Shapiro said.

That success makes for booming business. Cenegenics New York City is moving toward the end of the year to a much larger office on Wall Street to better accommodate their growth. The center also treats patients in the surrounding areas, including Pennsylvania, New Jersey, Connecticut and Rhode Island. Satellite offices are being planned throughout the metro area for patient convenience and to meet the demand for healthy aging solutions.

“Patients are our focus. We have restored the physician-patient relationship, offering substantial, quality office visits (not the conventional 10-minute), easy access to physicians, nutrition/fitness counselors and staff via phone, email, texting, Skype, etc.—in addition to 24/7 access via our Cenegenics Living Online (CLO), an online fitness/nutrition tracking program to bolster interconnectivity and a patient’s success with healthy aging goals,” Shapiro said.

Currently, Cenegenics New York City is located at 40 Wall Street/28th floor in the Trump Building. The new location will be on the 55th floor of 40 Wall Street. Cenegenics New York City may be reached at 646.512.5702.

Physicians in the New York tristate area can learn more about age management medicine and Cenegenics’ highly regarded physician training/certification program by contacting Dr. George Shapiro, Dr. Joseph Bosiljevac or Dr. Keith Fleischman at 646.512.5702.

Outside the New York tristate area, physicians can discover the rewarding benefits of practicing age management medicine and Cenegenics physician training/certification program by contacting Dr. Michael Resnick (702.953.1574) or Dr. Tim Patel (702.953.1577).

Visit Cenegenics’ Facebook Fan page, follow them on Twitter and get patient celebrity blogs, health tips and news on their portal site, CenegenicsPost.

For more information about Cenegenics, please visit them online, where you can register for quick access to the free online Cenegenics Healthy Aging Kit: informative Guide to Healthy Aging, Executive Summary and media excerpts.

To schedule an interview, please contact Ann Castro, Cenegenics Director of Media Relations: 702.953.1588.

About George Shapiro, MD, FACC Physician Partner, Cenegenics New York City
Dr. George Shapiro is board certified in cardiovascular disease. He also is trained and certified in age management medicine via the nonprofit Cenegenics Education and Research Foundation (CERF). For 15 years, he was the Medical Director of the Associates of Columbia Presbyterian Heart Institute (Scarsdale, New York), focused on preventive and age management medicine. He is an Adjunct Clinical Assistant Professor of Medicine at New York Medical College. Previously, he was a Clinical Assistant Professor of Medicine at New York University School of Medicine and Assistant Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons, where he was a member of the medical staff. His extensive community service includes: member of the Haz-Mat team for Westchester County Dept. of Emergency Services, volunteer firefighter/fire surgeon for Ardsley Fire Department, Chief Police Surgeon for the New York State Troopers. He also works with the AFYA foundation in setting up an Adult and Pediatric Cardiac Catheterization Laboratory and Heart Center in Haiti.

About Cenegenics
Cenegenics® Medical Institute has forged a paradigm shift in medicine, developing a proactive medical approach for optimized health hailed as “next generation medicine” and garnering worldwide media attention. Cenegenics has 21 centers with others opening in the near future: Las Vegas, Nevada (headquarters/2 centers); Charleston, SC; Boca Raton, Florida; Dallas, Texas; Arlington, Texas; Atlanta, Georgia; Chicago, Illinois; Beverly Hills, California; Philadelphia, Pennsylvania; Washington, DC; New York City, NY; Tulsa, OK; Jacksonville, FL; Atlantic City, NJ; Houston, TX; Denver, CO; Scottsdale, AZ; Boston, MA; Miami,FL; Charlotte, NC. Cenegenics serves over 20,000 patients globally—2,000 are physicians and their families.More from our newsroom

Low-Glycemic Nutrition Tops Others: Cenegenics Program Goes Beyond Harvard Medical School Research to Real-Life Application, Hormonal Balance, Maximized Results

LAS VEGAS, NV (PRWEB) AUGUST 23, 2012

The Cenegenics customized healthy aging program goes beyond the recent Harvard Medical School research on nutrition, published in the “Journal of the American Medical Association,” to real-life applications, demonstrating the positive impact low-glycemic nutrition has on hormonal balance, caloric control, body composition, glucose metabolism, inflammatory markers and satiety, announced Cenegenics® Medical Institute, the global leader in age management medicine. Pairing foods, clearly defined carbohydrate options and an individualized approach per each patient’s baseline—versus the generic ratios applied across the board in research and other nutritional plans—help Cenegenics target a patient’s health goals, from insulin management and body fat percentage to improved energy expenditure (calories burned).

A calorie is not a calorie, per this latest Harvard research, entitled “Effects of Dietary Composition on Energy Expenditure During Weight-Loss Maintenance.” There is a definite hormonal impact from food as well as a thermogenic effect. The low-glycemic diet proved to have a higher thermogenesis (higher resting energy expenditure) than a low-fat diet. The bottom line: High-glycemic foods elevate blood glucose and spike insulin levels, which results in a higher body fat percentage and more pounds of fat.

“It’s not just about body composition, but also the blood values—hemoglobin A1C, glucose and insulin—which indicate the amount and quality of carbohydrate you’re eating. We teach patients to not only choose the right low-glycemic carbohydrates within the right portions for their needs, but how to properly pair those foods with lean protein and healthful fats to avoid elevating insulin throughout the day. And it’s that approach that continues to help our patients achieve results,” Cenegenics Director of Nutrition/Exercise Rudy Inaba said.

Inaba also is the nutrition/exercise instructor for the Cenegenics Education and Research Foundation’s (CERF’s) highly regarded Physician Training and Certification in Age Management Medicine program.

In real-world applications, Cenegenics nutritionists can widen the door for more variety to see what fits an individual patient, rather than the blanketed 40-40-20 ratio used in the Harvard study, says Inaba.

“By choosing whole-food sources—low-glycemic carbohydrates (primarily vegetables and fruits), healthful fats (high in omega-3s/omega 9s), lean protein sources (low in saturated fats)—a patient has better control of the amount of glucose entering the bloodstream. That helps reduce the amount of insulin present in the blood and, as a result, allows the patient to feel more energized and use the body’s fat stores as a primary fuel source,” Inaba said.

Physicians can discover the rewarding benefits of practicing age management medicine and Cenegenics physician training/certification program by contacting Dr. Michael Resnick (702.953.1574) or Dr. Tim Patel (702.953.1577).

Visit Cenegenics’ Facebook Fan page, follow them on Twitter and get patient celebrity blogs, health tips and news on their portal site, CenegenicsPost.

For more information about Cenegenics, please visit them online, where you can register for quick access to the free online Cenegenics Healthy Aging Kit: informative Guide to Healthy Aging, Executive Summary and media excerpts.

To schedule an interview, please contact Ann Castro, Cenegenics Director of Media Relations: 702.953.1588.

About Cenegenics
Cenegenics® Medical Institute has forged a paradigm shift in medicine, developing a proactive medical approach for optimized health hailed as “next generation medicine” and garnering worldwide media attention. Cenegenics has 21 centers with others opening in the near future: Las Vegas, Nevada (headquarters/2 centers); Charleston, SC; Boca Raton, Florida; Dallas, Texas; Arlington, Texas; Atlanta, Georgia; Chicago, Illinois; Beverly Hills, California; Philadelphia, Pennsylvania; Washington, DC; New York City, NY; Tulsa, OK; Jacksonville, FL; Atlantic City, NJ; Houston, TX; Denver, CO; Scottsdale, AZ; Boston, MA; Miami,FL; Charlotte, NC. Cenegenics serves over 20,000 patients globally—2,000 are physicians and their families.

Nevada Chapter of Juvenile Diabetes Research Foundation Honors Cenegenics CEO John E. Adams at April 26th Gala of Hope

LAS VEGAS, NV (PRWEB) MARCH 21, 2013

The Nevada Chapter of the Juvenile Diabetes Research Foundation (JDRF) names Cenegenics CEO John E. Adams as honoree of their Gala of Hope 2013 fundraiser, being held at the Mandalay Bay Resort & Casino on Friday, April 26, announced Cenegenics, the global leader in age management medicine. The JDRF selected Adams for his continued support of JDRF and for his many contributions to the communities of Southern Nevada.

Adams cofounded Cenegenics back in 1997, along with Dr. Alan P. Mintz, pioneering the medical specialty of age management medicine. Cenegenics’ focus then and now is a proactive, preventive medical approach to maximize health, wellness and vitality so people live well longer—an objective that mirrors the JDRF global agenda to find ways to better treat or prevent diabetes.

“JDRF’s unwavering commitment and research support to discover preventive strategies and a cure for type 1 diabetes are remarkable. I am deeply honored to support and be recognized by this ‘All-Star’ charity whose fine work and mission help people worldwide attain a healthier, better-quality life,” Adams said.

The Gala of Hope fundraiser will feature a cocktail reception, silent and live auctions, gourmet dinner with wine and energy-infused entertainment throughout the evening.  Last year’s Gala attracted nearly 700 guests and raised over $850,000 for type 1 diabetes research.

“John Adams has always been a leader, using his gifts to help others and to create community. He approaches his life, health, fitness, education, career, business, family and friends with integrity and passion. It has been a pleasure to know him for over 30 years, which is why it is my great privilege to be joined by The Las Vegas Chapter of JDRF fellow board members and the JDRF Las Vegas community in recognizing John Adams at this year’s Gala,” JDRF Board of Directors Member for Special Projects Pia Exber-Morris said. 

Individual tickets for the 2013 JDRF Gala of Hope are $350. Sponsorships include $3,500 (Table Sponsor), $5k (Inspiration Sponsor), $10K (Vision Sponsor), $15K (Dream Sponsor) and $25K (Hope Sponsor).  

For more information on event details, sponsorship, donation and ticket options, an auction preview, advance registration and volunteer sign-up forms, please contact Joyce Conroy, Special Event Manager at 702.732.4795 or via email at jconroy(at)jdrf(dot)org. 

Follow Cenegenics on FacebookTwitter and get health tips, patient celebrity blogs and health news on their portal site, CenegenicsPost.

For more information about Cenegenics, please visit them online to learn more about taking control of your health. To schedule an interview, please contact Ann Castro, Cenegenics Director of Media Relations: 702.953.1588.

About John E. Adams 
Cenegenics®  CEO 
Mr. John E. Adams is the cofounder and CEO of the global leader in proactive, preventive medicine, Cenegenics®. He also is the founder/chairman of the World Presidents’ Organization – Las Vegas Chapter and an Honorary Commander at Creech Air Force Base, home of the Predator unmanned aerial vehicle. He serves on the University of Illinois at Chicago Dean’s Business Advisory Council and Executive Committee of the College of Business Administration. In addition, he was appointed to the Presidents Council at the University of Illinois. He is a Platinum Sponsor for the Andre Agassi Foundation for Education, the University of Illinois at Chicago College of Business Administration and the Crohn’s and Colitis Foundation of America. Mr. Adams is an INVENTORS capital campaign supporter for the Discovery Children’s Museum and holds memberships in the World Presidents’ Organization – Las Vegas and Chicago Chapters, Chief Executives Organization, Economic Club of Chicago, and the international gastronomic society, La Chaîne des Rôtisseurs™. Formerly, he was chairman of the Young Presidents Organization – Las Vegas and served six years on its board. His first entrepreneurial venture was as cofounder, executive vice president and chief operating officer of Medicon, Inc.—the world’s largest radiology management company. Prior to that, Mr. Adams was a certified public accountant for Arthur Andersen & Company’s Emerging Business Group in Chicago. He is a University of Illinois at Chicago graduate.  
  
About JDRF 
JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents and adults with this disease, JDRF is now the largest charitable supporter of T1D research. The goal of JDRF research is to improve the lives of all people affected by T1D by accelerating progress on the most promising opportunities for curing, better treating and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal. Since its founding in 1970, JDRF has awarded more than $1.7 billion to diabetes research. Past JDRF efforts have helped to significantly advance the care of people with this disease and have expanded the critical scientific understanding of T1D. JDRF will not rest until T1D is fully conquered. More than 80 percent of JDRF’s expenditures directly support research and research-related education.

About Cenegenics 
Cenegenics® has forged a paradigm shift in medicine with its Elite Health Program, developing a proactive medical approach for maximized health, vitality and wellness, hailed as “next generation medicine” and garnering worldwide media attention. Cenegenics has 21 centers with others opening in the near future: Las Vegas, Nevada (headquarters/2 centers); Charleston, SC; Boca Raton, FL; Dallas, TX; Arlington, TX; Atlanta, GA; Chicago, IL; Beverly Hills, CA; Philadelphia, PA; Washington, DC; New York City, NY; Tulsa, OK; Jacksonville, FL; Atlantic City, NJ; Houston, TX; Denver, CO; Scottsdale, AZ; Boston, MA; Miami,FL; Charlotte, NC; San Juan, Puerto Rico. Cenegenics serves over 20,000 patients globally—2,000 are physicians and their families. 
###

Featured Study in Journal Of Geriatric Cardiology: Physician-Supervised Program For Boomer, Obese Men Reduces Cardio Risk Factors

LAS VEGAS, NV (PRWEB) JANUARY 20, 2012

The recent Journal of Geriatric Cardiology (Volume 8, issue 4) featured a retrospective data analysis study of Cenegenics’ commercially available program for middle-aged, obese men that revealed a surprising reduction in cardiovascular risk factors, announced Cenegenics® Medical Institute. The study—a collaborative effort with Dr. Ernst R. von Schwarz, Chief Medical Officer of the Heart Institute of Southern California and professor of medicine at UCLA’s David Geffen School of Medicine—centered on Cenegenics’ physician-supervised program encompassing nutrition, exercise and testosterone replacement therapy.

According to Cenegenics, the study is the first reporting demonstrating the beneficial effects of a combined, commercially available nutrition/exercise program with testosterone replacement in men who had a clinical indication. Although it is not a randomized controlled prospective study, the findings from the non-randomized study revealed highly significant changes. However, the global leader says further controlled prospective studies should be performed to confirm this initial data.

“Having this article—the first scientific retrospective analysis of Cenegenics-treated patients—featured on the title page of the open access Journal of Geriatric Cardiology underlines the importance and interest among a large readership on the topic of testosterone therapy for older men,” Schwarz said.

Male patients fell within a median age of 52 (± 7.8 years). Over a 6- to 18-month follow up, participants showed a significant reduction in weight and body fat as well as fasting glucose levels, lipids and total cholesterol levels—all are major risk factors for cardiovascular disease. None of the participants had diabetes, hypertension or cardiovascular disease.

The physician-supervised program encompassed low-glycemic nutrition, interval training and weight training as well as testosterone therapy, with no adverse effects. The statistically significant findings are prompting Cenegenics to consider broadening their parameters, reaching out to high-risk patients who aren’t ill yet, but who could benefit from their risk-reduction program.

“This study shows we can markedly reduce risk factors for the development of chronic illness, such as atherosclerosis . . . and that it takes more than a wellness program to optimize health. From its 1997 beginnings, Cenegenics’ medical system has been based on balance—nutrition/nutraceuticals, exercise and hormone optimization as well as ongoing physician follow-ups. We’re in the business of taking medicine to new directions and heights, not waiting for people to get sick before they’re treated.Our 14- year experience shows the Cenegenics program makes a difference,” Dr. Robert D. Willix, Jr. said.

Willix is Cenegenics’ Chief Medical Officer and CEO/Chief Medical Officer of Cenegenics Boca Raton.

Visit Cenegenics’ Facebook Fan page, follow them on Twitter and get patient celebrity blogs and health tips.

For more information about Cenegenics, please visit them online, where you can register for quick access to the online Cenegenics Healthy Aging Kit: informative Guide to Healthy Aging, Executive Summary and media excerpts.

Physicians can learn more about age management medicine directly by calling Cenegenics: Dr. Michael Resnick at 702.953.1574 or Dr. Tim Patel at 702.953.1577. Or visit Cenegenics’ physician site to learn more about Cenegenics’ highly regarded, CME-accredited Physician Training & Certification in Age Management Medicine program.

To schedule an interview, please contact Ann Castro, Cenegenics Director of Media Relations: 702.953.1588.

About Ernst R. von Schwarz, MD, PhD, FESC, FACC, FSCAI
Dr. Ernst R. von Schwarz is board certified in internal medicine by the American Board of Internal Medicine and in cardiology/cardiovascular diseases by the American Board of Internal Medicine. He is Chief Medical Officer of the Heart Institute of Southern California and a noted professor of medicine at UCLA’s David Geffen School of Medicine. As a clinician and scientist, Schwarz has written more than 100 articles for peer-reviewed publications and has written 10 book chapters on cardiovascular medicine.

About Cenegenics
Cenegenics® Medical Institute has forged a paradigm shift in medicine, developing a proactive medical approach for optimized health hailed as “next generation medicine” and garnering worldwide media attention. Headquartered in Las Vegas, Cenegenics serves over 20,000 patients globally—2,000 are physicians and their families. Cenegenics has 19 centers with others opening in the near future: Las Vegas, Nevada; Charleston, South Carolina; Boca Raton, Florida; Dallas, Texas; Arlington, Texas; Atlanta, Georgia; Chicago, Illinois; Beverly Hills, California; Philadelphia, Pennsylvania; Washington, DC; New York City, NY; Tulsa, OK; Jacksonville, FL; Atlantic City, NJ; Houston,TX; Denver, CO; Scottsdale, AZ; Boston, MA. Cenegenics also offers CME-accredited physician training and certification opportunities in age management medicine via the nonprofit Cenegenics Education and Research Foundation (CERF).More from our newsroom

Global Health Leader Launches Uniquely Advanced Heart Disease & Stroke Prevention Program, Centered on Next Generation Medicine

LAS VEGAS, NV (PRWEB) JANUARY 24, 2012

Cenegenics® Medical Institute launched a unique Heart Disease & Stroke Prevention Program this month that sets a new benchmark for preventive health, announced the age management medicine global leader. Partnering with three cardio-diagnostic leaders—Panasonic Healthcare Group, Berkeley HeartLab and Cleveland HeartLab™—Cenegenics created the most advanced program, combining the best aspects of the nation’s top laboratories who screen for cardiovascular disease. No other practice does that.

Cardiovascular disease claims more lives ever year than all cancers, diabetes, Alzheimer’s or accidents, per the AHA’s 2011 Heart Disease/Stroke update. Cenegenics is targeting the disease head on with next generation medicine and an innovative program designed by four experts in the field: Dr. Robert D. Willix, Jr., a former cardiovascular surgeon and Cenegenics’ Chief Medical Officer; and three cardiologists, Dr. George Shapiro (Cenegenics New York City), Dr. Cesar Pellerano (Cenegenics Miami) and Dr. Ernst Schwarz (professor of Medicine, UCLA’s David Geffen School of Medicine).

“Up until now, Cenegenics has focused entirely on age management medicine and proactive health. Our new Heart Disease & Stroke Prevention Program with an advanced screening technology is our first endeavor to not only target an illness, but show how our Cenegenics program can reduce the development of disease,” Willix said.

Cenegenics’ Heart Disease & Stroke Prevention Program is available to everyone, patient or not, and is recommended for a wide age group.

  •     Critical for future health—if you have a family history of heart disease or stroke
  •     Avoid future events—if you’ve had cardiovascular disease or had bypass surgery, heart attack or stroke
  •     Life saving—for everyone regardless of age, from 13 to 60 or older

“Can you prevent premature death, a heart attack or stroke? Yes, but you’ve got to know the warning signs. Cenegenics helps you do that with our unique Heart Disease & Stroke Prevention Program, which includes genetic screening, advanced lipid panels, laboratory markers for plaque formation and assessments for inflammatory markers—a cause of cardiovascular disease leading to tissue damage, organ destruction, shift in the cellular matrix as well as potential blood clots and heart attacks,” Willix said.

Learn more about Cenegenics’ Heart Disease & Stroke Prevention Program by calling 888.412.8769.

Visit Cenegenics’ Facebook Fan page, follow them on Twitter and get patient celebrity blogs, health tips and news on their portal site, CenegenicsPost.

For more information about Cenegenics, please visit them online, where you can register for quick access to the online Cenegenics Healthy Aging Kit: informative Guide to Healthy Aging, Executive Summary and media excerpts.

Physicians can learn more about age management medicine directly by calling Cenegenics: Or visit the Cenegenics physician site to learn more about Cenegenics’ highly regarded, CME-accredited Physician Training & Certification in Age Management Medicine program.

About Cenegenics
Cenegenics® Medical Institute has forged a paradigm shift in medicine, developing a proactive medical approach for optimized health hailed as “next generation medicine” and garnering worldwide media attention. Headquartered in Las Vegas, Cenegenics serves over 20,000 patients globally—2,000 are physicians and their families. Cenegenics has 19 centers with others opening in the near future: Las Vegas, Nevada; Charleston, South Carolina; Boca Raton, Florida; Dallas, Texas; Arlington, Texas; Atlanta, Georgia; Chicago, Illinois; Beverly Hills, California; Philadelphia, Pennsylvania; Washington, DC; New York City, NY; Tulsa, OK; Jacksonville, FL; Atlantic City, NJ; Houston,TX; Denver, CO; Scottsdale, AZ; Boston, MA. Cenegenics also offers CME-accredited physician training and certification opportunities in age management medicine via the nonprofit Cenegenics Education and Research Foundation (CERF).More from our newsroom

>